Welcome to the CBF

The Clinical BioManufacturing Facility (CBF) has over 20 years experience producing biological Investigational Medicinal Products (IMPs) according to GMP for early phase clinical trials.

Read more about the CBF

Related Publications

Prime-boost vaccination with chimpanzee adenovirus and modified vaccinia Ankara encoding TRAP provides partial protection against Plasmodium falciparum infection in Kenyan adults

Ogwang C.  et al.

Science Translational Medicine, May 2015

See all related publications

Latest News

CBF listed on KTN’s Innovation Landscape for the Medicines Manufacturing Sector

Posted 09/12/2015

A new web portal (http://www.mmlandscape.ktn-uk.org/) was launched at the recent 12th Annual bioProcessUK Conference held in Cambridge on 25/6 November 2015. The portal developed by the Knowledge Transfer Network (KTN) on behalf of the Medicines Manufacturing Industry Partnership (MMIP) pulls together the innovation landscape, company base and ...

See all news